Related Experiment Video
Updated: Jul 5, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Challenges of lupus pregnancies
A Doria1, A Tincani, M Lockshin
1Department of Clinical and Experimental Medicine, Division of Rheumatology, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy. adoria@unipd.it
Rheumatology (Oxford, England)
|June 25, 2008
Summary
Systemic lupus erythematosus (SLE) affects young women, but fertility is usually preserved. While pregnancy poses challenges for SLE patients, successful outcomes are achievable with proper monitoring and management.
Area of Science:
- Immunology
- Rheumatology
- Obstetrics
Background:
- Systemic lupus erythematosus (SLE) predominantly affects women of childbearing age.
- Fertility is generally conserved in SLE patients.
- SLE involves a Th2-mediated immune response with a progressive Th1/Th2 cytokine shift during pregnancy.
Purpose of the Study:
- To review the challenges and management of pregnancy in patients with SLE.
- To discuss the impact of SLE on pregnancy outcomes.
- To highlight the importance of multidisciplinary monitoring for successful pregnancies in SLE patients.
Main Methods:
- This review synthesizes current knowledge on SLE and pregnancy.
- It discusses risks, preventive strategies, and therapeutic measures.
- Emphasis is placed on integrated rheumatological, obstetric, and neonatal care.
Main Results:
- Despite SLE, the majority of patients can achieve successful pregnancies.
- Advances in understanding SLE risks and management have improved outcomes.
- Close monitoring is crucial for managing SLE during pregnancy.
Conclusions:
- Pregnancy in SLE patients is challenging but manageable.
- Successful outcomes depend on proactive management and multidisciplinary care.
- Knowledge of SLE's impact on pregnancy allows for better patient care and healthier babies.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...